CELEX: 32010M6001
Language: en
Date: 2010-11-11 00:00:00
Title: Commission Decision of 11/11/2010 declaring a concentration to be compatible with the common market (Case No COMP/M.6001 - AKER / LINDSAY GOLDBERG / EPAX HOLDING) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)

|

32010M6001

Commission Decision of 11/11/2010 declaring a concentration to be compatible with the common market (Case No COMP/M.6001 - AKER / LINDSAY GOLDBERG / EPAX HOLDING) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)  

         (.PICT.) |EUROPEAN COMMISSION     |
             Brussels, 11.11.2010
             SG-Greffe(2010) D/18054/18055
            C(2010) 7946
              PUBLIC VERSION
             MERGER PROCEDURE ARTICLE 6(1)(b) DECISION
             SIMPLIFIED PROCEDURE
                    To the notifying parties: 
             Dear Madam(s) and/or Sir(s),
             Subject: Case No COMP/M.6001 - AKER/ LINDSAY GOLDBERG/ EPAX HOLDING Notification of 06.10.2010 pursuant to Article 4 of Council Regulation (EC) No 139/2004  [1]  Publication in the Official Journal of the European Union No C 277, 14.10.2010, p.18
            (1)  On 06.10.2010, the European Commission received notification of a proposed concentration pursuant to Article 4 of the Merger Regulation by which the undertakings Aker BioMarine ASA ("ABM"), Norway, via its wholly owned subsidiary Trygg Pharma AS, and Lindsay Goldberg LLC ("LG"), United States, acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the undertaking EPAX Holding ASA ("EPAX"), Norway, by way of purchase of shares.
            (2)  The business activities of the undertakings concerned are:
             - for undertaking ABM : harvesting of Antarctic krill and production of derived products such as krill meal and krill oil.
             - for undertaking LG : long term investments in companies with growth opportunities in a range of businesses around the world.
             - for undertaking EPAX : production of concentrated fish oil for use in various dietary supplements in the health food segment.
            (3)  After examination of the notification, the European Commission has concluded that the notified operation falls within the scope of the Merger Regulation and of paragraph 5(b) of the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 [2]  .  
            (4)  For the reasons set out in the Notice on a simplified procedure, the European Commission has decided not to oppose the notified operation and to declare it compatible with the internal market and with the EEA Agreement. This decision is adopted in application of Article 6(1)(b) of the Merger Regulation.
             For the European Commission, (signed) Alexander ITALIANER Director General
            [1]OJ L 24, 29.1.2004, p. 1 ("the Merger Regulation"). With effect from 1 December 2009, the Treaty on the Functioning of the European Union ("TFEU") has introduced certain changes, such as the replacement of "Community" by "Union" and "common market" by "internal market". The terminology of the TFEU will be used throughout this decision.
            [2] OJ C 56, 5.3.2005, p. 32.